Completed

Observational Study of Pediatric Migraine: The Pediatric Migraine Registry

What is being collected

Data Collection

Collected from today forward - Prospective

DNA Samples

Who is being recruted

Brain Diseases+3

+ Central Nervous System Diseases

+ Migraine Disorders

From 4 to 17 Years

+5 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.

Observational

Study Start: December 2018

See protocol details

Summary

Principal SponsorDuke University

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: December 5, 2018

Actual date on which the first participant was enrolled.

This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated with migraine.

Official TitleObservational Study of Pediatric Migraine: The Pediatric Migraine Registry

NCT03742024

Principal SponsorDuke University

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

201 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 4 to 17 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Brain DiseasesCentral Nervous System DiseasesMigraine DisordersNervous System DiseasesHeadache DisordersHeadache Disorders, Primary

Criteria

4 inclusion criteria required to participate

4 to 17 years of age inclusive at the time of enrollment visit

Meets International Classification of Headache Disorders, 3rd edition criteria for migraine with or without aura

Guardian provides informed consent/HIPAA

Participant provides assent if developmentally appropriate and required by the institutional review board

1 exclusion criteria prevent from participating

Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 19 locations

Suspended

University of California at San Francisco

San Francisco, United StatesOpen University of California at San Francisco in Google Maps

Suspended

Colorado Springs Neurological Associates

Colorado Springs, United States

Suspended

Nemours Alfred I duPont Hospital For Children Neurology

Wilmington, United States

Suspended

Nicklaus Children's Hospital

Miami, United States

Completed19 Study Centers